Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven ...
ABL Diagnostics (Euronext: ABLD - ISIN: FR001400AHX6) informs its shareholders and the market that Advanced Biological Laboratories S.A. ("ABL S.A."), its controlling shareholder, and ProPhase Labs, ...
Investing.com -- ProPhase Labs Inc (NASDAQ:PRPH) stock surged 75.2% in premarket trading Friday after the company announced a ...
TipRanks on MSN
ProPhase Labs announces proposed reverse merger with ABL
Prophase Labs ( ($PRPH) ) just unveiled an update. ProPhase Labs, Inc. announced that it has entered into a non-binding letter of intent for a ...
ProPhase Labs, Inc. (PRPH) shares ended the last trading session 8.5% higher at $8.42. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
Detailed price information for Prophase Labs Inc (PRPH-Q) from The Globe and Mail including charting and trades.
ProPhase Labs (NASDAQ:PRPH) stock rose +12% Tuesday premarket as it named Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company’s expansion into consumer-centered health ...
GARDEN CITY, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announces the ...
ProPhase Labs (PRPH) and Advanced Biological Laboratories entered into a non-binding Letter of Intent regarding a proposed reverse merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback